These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1613888)

  • 1. Correlation of prostate cancer nuclear deoxyribonucleic acid, size, shape and Gleason grade with pathological stage at radical prostatectomy.
    Epstein JI; Pizov G; Steinberg GD; Carter HB; Pitcock R; Armas OA; Partin A; Walsh PC
    J Urol; 1992 Jul; 148(1):87-91. PubMed ID: 1613888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deoxyribonucleic acid ploidy analysis as a predictor of recurrence following radical prostatectomy for stage T2 disease.
    Carmichael MJ; Veltri RW; Partin AW; Miller MC; Walsh PC; Epstein JI
    J Urol; 1995 Mar; 153(3 Pt 2):1015-9. PubMed ID: 7853549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric determination of ploidy in prostatic adenocarcinoma: a comparison with seminal vesicle involvement and histopathological grading as a predictor of clinical recurrence.
    Lee SE; Currin SM; Paulson DF; Walther PJ
    J Urol; 1988 Oct; 140(4):769-74. PubMed ID: 3047437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup.
    Epstein JI; Carmichael M; Partin AW; Walsh PC
    J Urol; 1993 Jun; 149(6):1478-81. PubMed ID: 8501792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate.
    Oesterling JE; Brendler CB; Epstein JI; Kimball AW; Walsh PC
    J Urol; 1987 Jul; 138(1):92-8. PubMed ID: 3599229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of capsular perforation and seminal vesicle invasion in prostate cancer.
    Bostwick DG; Qian J; Bergstralh E; Dundore P; Dugan J; Myers RP; Oesterling JE
    J Urol; 1996 Apr; 155(4):1361-7. PubMed ID: 8632575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of pathologic stage and postprostatectomy disease recurrence by DNA ploidy analysis of initial needle biopsy specimens of prostate cancer.
    Ross JS; Figge H; Bui HX; del Rosario AD; Jennings TA; Rifkin MD; Fisher HA
    Cancer; 1994 Nov; 74(10):2811-8. PubMed ID: 7954242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radical prostatectomy for impalpable prostate cancer: the Johns Hopkins experience with tumors found on transurethral resection (stages T1A and T1B) and on needle biopsy (stage T1C).
    Epstein JI; Walsh PC; Brendler CB
    J Urol; 1994 Nov; 152(5 Pt 2):1721-9. PubMed ID: 7523719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA in radical prostatectomy specimens. Prognostic value of tumor ploidy.
    Robertson CN; Paulson DF
    Acta Oncol; 1991; 30(2):205-7. PubMed ID: 2029406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of prognostic factors in men undergoing radical prostatectomy for adenocarcinoma of the prostate, including DNA ploidy, surgical tumor stage, prostatic specific antigen, Gleason grade, and age.
    Shockley KF; Maatman TJ; Carothers GC; Warzynski MJ
    Prostate; 1996 Jul; 29(1):46-50. PubMed ID: 8685055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update.
    Partin AW; Kattan MW; Subong EN; Walsh PC; Wojno KJ; Oesterling JE; Scardino PT; Pearson JD
    JAMA; 1997 May; 277(18):1445-51. PubMed ID: 9145716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers.
    Noguchi M; Stamey TA; McNeal JE; Yemoto CM
    J Urol; 2000 Nov; 164(5):1596-600. PubMed ID: 11025712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining prostate specific antigen with cancer and gland volume to predict more reliably pathological stage: the influence of prostate specific antigen cancer density.
    Blackwell KL; Bostwick DG; Myers RP; Zincke H; Oesterling JE
    J Urol; 1994 Jun; 151(6):1565-70. PubMed ID: 7514689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some small prostate cancers are nondiploid by nuclear image analysis: correlation of deoxyribonucleic acid ploidy status and pathological features.
    Greene DR; Rogers E; Wessels EC; Wheeler TM; Taylor SR; Santucci RA; Thompson TC; Scardino PT
    J Urol; 1994 May; 151(5):1301-7. PubMed ID: 8158775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can ploidy of prostate carcinoma diagnosed on needle biopsy predict radical prostatectomy stage and grade?
    Brinker DA; Ross JS; Tran TA; Jones DM; Epstein JI
    J Urol; 1999 Dec; 162(6):2036-9. PubMed ID: 10569563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between the preoperative serum prostate specific antigen, Gleason score, and clinical staging with pathological outcome following robot-assisted radical prostatectomy: an Indian experience.
    Singh P; Dogra PN; Gupta NP; Nayyar R; Seth A; Javali TD; Kumar R
    Indian J Cancer; 2011; 48(4):483-7. PubMed ID: 22293265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of nuclear DNA ploidy patterns in patients with prostate cancer after radical prostatectomy.
    Wirth MP; Müller HA; Manseck A; Müller J; Frohmüller HG
    Eur Urol; 1991; 20(3):248-52. PubMed ID: 1823048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
    J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern of failure after radical retropubic prostatectomy for clinically and pathologically localized adenocarcinoma of the prostate: influence of tumor deoxyribonucleic acid ploidy.
    Blute ML; Nativ O; Zincke H; Farrow GM; Therneau T; Lieber MM
    J Urol; 1989 Nov; 142(5):1262-5. PubMed ID: 2810503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in localized prostatic carcinoma.
    Pontes JE; Wajsman Z; Huben RP; Wolf RM; Englander LS
    J Urol; 1985 Dec; 134(6):1137-9. PubMed ID: 4057404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.